Prognostic value of pan-immune inflammation value in patients with ulcerative colitis

Read full text Summarise with VIRAT
Authors: Yalcin Yerhan, Murat İspiroğlu, Nurten Seringeç, Kadir Gişi, Bülent Kantarçeken
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: A novel index called the pan-immune inflammation value (PIV) reflects the body's systemic inflammation and immunological response.This study aimed to determine whether the PIV can be used as a diagnostic biomarker in assessing disease activity in patients with ulcerative colitis (UC). Materials and Methods:According to the Truelove and Witts criteria, this retrospective study included 64 clinically active UC patients and 64 UC patients in remission.For the differential diagnosis of active UC patients from patients in remission, the cut-off value was estimated by making receiver-operator curves (ROC) of PIV, platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR).Results: There were no significant differences between the active UC patients and UC patients in remission regarding demographic characteristics such as age and gender.C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), NLR, PLR, and PIV were significantly elevated in active UC patients than those in remission (p

Fields of Study & Subjects

Inflammatory Bowel Disease Inflammatory Biomarkers in Disease Prognosis Ocular Diseases and Behçet’s Syndrome

Publication details

Journal / source
Laparoscopic Endoscopic Surgical Science
Pages
1–6
Publication date
1 January 2026
Language
EN